MUC5AC and lung cancer: Besides, patients with both high MUC5AC and low circRABL2B exerted the worst survival after adjustment for age, sex, smoking status, family history of lung cancer, and clinical stage (HR=2.00; 95%CI=1.12-3.57; Fig. 1m, Table 1).